311 results
Page 12 of 16
424B5
um8 3thlhu2b1
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
4yx9b crdq1
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
pwe88d0w45xn9q ww
24 Feb 14
BioLineRx Appoints Dr. Sandra Panem to
12:00am
6-K
EX-99
r6fn4lyh3m4wbom
23 Jan 14
BioLineRx Receives Orphan Drug
12:00am
6-K
EX-99
lkmnhk
21 Jan 14
BioLineRx Receives Approval to Commence
12:00am
6-K
EX-99
nm6bmb6moxx86p
13 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
7vzwlogoj2q63xibmd8
8 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
resg3nnd6jb
18 Dec 13
Current report (foreign)
12:00am
6-K
EX-99
qie 1tw6b3e2
16 Dec 13
BioLineRx Announces Promising Initial Phase 2
12:00am
6-K
EX-99
p1bdn61vqius84
10 Dec 13
BioLineRx Presents Positive Preclinical Results of
12:00am
6-K
EX-99
o94zgp3y
26 Nov 13
Current report (foreign)
12:00am
6-K
EX-99
vyk nvbvozc
19 Nov 13
BioLineRx Reports Publication in Peer Review Journal
12:00am
6-K
EX-99
mda2el4owk zc0o
4 Nov 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
6-K
EX-99
bjibtenacc4x1 ii
23 Oct 13
Current report (foreign)
12:00am
6-K
EX-99
vwnr9wffm
7 Oct 13
BioLineRx Announces Receipt of Notice of Allowance
12:00am
6-K
EX-99
3mu68
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
6-K
EX-99
jpi86
17 Sep 13
BioLineRx Announces Receipt of a Notice of Allowance
12:00am
6-K
EX-99
2kt5h7pbatgoiyw4
9 Sep 13
BioLineRx’s BL-8040 Receives Orphan Drug
12:00am
6-K
EX-99
stnvzu28djrqshn8f3
3 Sep 13
BioLineRx Announces Issuance of United States Patent
12:00am
6-K
EX-99
qxdeli1p4ngfq
19 Aug 13
BioLineRx Appoints B. J. Bormann to
12:00am